Skip to content
PubMed This is a summary of 113 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 113 referenced papers

Top Authors

Narsing A. Rao
Doheny Eye Institute
Ghazala O’Keefe
Emory University
Peizeng Yang
The Affiliated Yongchuan Hospital of Chongqing Medical University
Douglas A. Jabs
Johns Hopkins Medicine
Rupesh Agrawal
National University of Singapore
Zhenyu Zhong
The Affiliated Yongchuan Hospital of Chongqing Medical University
P. Sève
Université Claude Bernard Lyon 1
John H. Kempen
Massachusetts Eye and Ear Infirmary
Carlos Pavésio
Moorfields Eye Hospital NHS Foundation Trust

Top Institutions

Ranked by publications Top 10 institutions
01

The Affiliated Yongchuan Hospital of Chongqing Medical University

Chongqing, China

101 papers
02

Sun Yat-sen University

Guangzhou, China

82 papers

References

References (113)
  1. 1

    Bilateral papillitis and unilateral focal chorioretinitis as the presenting features of syphilis.

    Benson CE, Soliman MK, Knezevic A, et al.

    Journal of ophthalmic inflammation and infection 2015; (5()):16 doi:10.1186/s12348-015-0045-0.

    PMID: 26069511
  2. 2

    Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues.

    Cordero-Coma M, Salazar-Méndez R, Yilmaz T

    Expert opinion on drug safety 2015; (14(9)):1353-71 doi:10.1517/14740338.2015.1061992.

    PMID: 26118392
  3. 3

    The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis.

    Kothari S, Foster CS, Pistilli M, et al.

    Ophthalmology 2015; (122(10)):1987-2001.

    PMID: 26233626
  4. 4

    Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study.

    Ophthalmology 2015; (122(10)):1976-86.

    PMID: 26298718
  5. 5

    Uveitis.

    Dunn JP

    Primary care 2015; (42(3)):305-23.

    PMID: 26319340
  6. 6

    Structure-function Relationships in Uveitic Cystoid Macular Edema: Using En Face Optical Coherence Tomography to Predict Vision.

    Cohen LM, Goldstein DA, Fawzi AA

    Ocular immunology and inflammation 2016; (24(3)):274-81 doi:10.3109/09273948.2015.1056535.

    PMID: 26471011
  7. 7

    Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial.

    Sen HN, Abreu FM, Louis TA, et al.

    Ophthalmology 2016; (123(1)):183-90.

    PMID: 26499920
  8. 8

    Management of Cytomegalovirus Retinitis in HIV and Non-HIV Patients.

    Pearce WA, Yeh S, Fine HF

    Ophthalmic surgery, lasers & imaging retina 2016; (47(2)):103-7 doi:10.3928/23258160-20160126-01.

    PMID: 26878441
  9. 9

    Visual Functioning and Health-related Quality-of-Life are Compromised in Patients with Uveitis.

    Hui MM, Wakefield D, Patel I, et al.

    Ocular immunology and inflammation 2017; (25(4)):486-491 doi:10.3109/09273948.2016.1139734.

    PMID: 27002552
  10. 10

    Discrepancies in assessing anterior chamber activity among uveitis specialists.

    Yeo TH, Ilangovan S, Keane PA, et al.

    Japanese journal of ophthalmology 2016; (60(3)):206-11 doi:10.1007/s10384-016-0438-0.

    PMID: 27020454
  11. 11

    Discrepancies between Spectral Domain Optical Coherence Tomography and Fluorescein Angiography in Detecting Uveitic Macular Edema.

    Mitkova-Hristova VT, Konareva-Kostianeva MI, Balian AM, et al.

    Folia medica 2015; (57(3-4)):207-15.

    PMID: 27180347
  12. 12

    Serial Frequencies and Clinical Features of Uveitis in Hokkaido, Japan.

    Iwata D, Mizuuchi K, Aoki K, et al.

    Ocular immunology and inflammation 2017; (25(sup1)):S15-S18 doi:10.1080/09273948.2016.1184286.

    PMID: 27438588
  13. 13

    Steroid-induced glaucoma in the pediatric population.

    Nuyen B, Weinreb RN, Robbins SL

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2017; (21(1)):1-6 doi:10.1016/j.jaapos.2016.09.026.

    PMID: 28087345
  14. 14

    Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.

    Daniel E, Pistilli M, Kothari S, et al.

    Ophthalmology 2017; (124(8)):1196-1208 doi:10.1016/j.ophtha.2017.03.041.

    PMID: 28433444
  15. 15

    Retrospective Study Evaluating Treatment Decisions and Outcomes of Childhood Uveitis Not Associated with Juvenile Idiopathic Arthritis.

    Sardar E, Dusser P, Rousseau A, et al.

    The Journal of pediatrics 2017; (186()):131-137.e1 doi:10.1016/j.jpeds.2017.03.052.

    PMID: 28457525
  16. 16

    Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis.

    Sen ES, Morgan MJ, MacLeod R, et al.

    Pediatric rheumatology online journal 2017; (15(1)):58 doi:10.1186/s12969-017-0189-6.

    PMID: 28778202
  17. 17

    [Prognostic factors in uveitis].

    Albaroudi N, Tijani M, Boutimzine N, et al.

    Journal francais d'ophtalmologie 2017; (40(9)):751-757 doi:10.1016/j.jfo.2017.04.005.

    PMID: 28882393
  18. 18

    Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.

    Groen-Hakan F, Eurelings L, ten Berge JC, et al.

    JAMA ophthalmology 2017; (135(12)):1352-1358 doi:10.1001/jamaophthalmol.2017.4771.

    PMID: 29121154
  19. 19

    Cataract Surgery Complications in Uveitis Patients: A Review Article.

    Llop SM, Papaliodis GN

    Seminars in ophthalmology 2018; (33(1)):64-69 doi:10.1080/08820538.2017.1353815.

    PMID: 29185838
  20. 20

    Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis).

    Grumet P, Kodjikian L, de Parisot A, et al.

    Autoimmunity reviews 2018; (17(4)):331-343 doi:10.1016/j.autrev.2017.10.018.

    PMID: 29427823
  21. 21

    [Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel].

    Diwo E, Sève P, Trad S, et al.

    La Revue de medecine interne 2018; (39(9)):687-698 doi:10.1016/j.revmed.2018.03.001.

    PMID: 29610003
  22. 22

    Varicella zoster virus cerebral aneurysmal vasculopathy presenting in a newly-diagnosed HIV-positive patient.

    Tomkins A, Babu C, Herwadkar A, et al.

    International journal of STD & AIDS 2018; (29(13)):1351-1353 doi:10.1177/0956462418786334.

    PMID: 30049255
  23. 23

    Etiological and Clinical Characteristics of HLA-B27-associated Uveitis in a Tertiary Referral Center

    İnanç M, Şimşek M, Çakar Özdal MP

    Turkish journal of ophthalmology 2019; (49(1)):10-14 doi:10.4274/tjo.galenos.2018.53896.

    PMID: 30829019
  24. 24

    Expert opinion on the use of biological therapy in non-infectious uveitis.

    Touhami S, Diwo E, Sève P, et al.

    Expert opinion on biological therapy 2019; (19(5)):477-490 doi:10.1080/14712598.2019.1595578.

    PMID: 30888881
  25. 25

    West Indies Glaucoma Laser Study (WIGLS) 3. Anterior Chamber Inflammation Following Selective Laser Trabeculoplasty in Afro-Caribbeans with Open-angle Glaucoma.

    Realini T, Shillingford-Ricketts H, Burt D, Balasubramani GK

    Journal of glaucoma 2019; (28(7)):622-625 doi:10.1097/IJG.0000000000001250.

    PMID: 30921277
  26. 26

    Steroid Induced Cataract in Langerhans Cell Histiocytosis Patient.

    Sutyawan WE, Widiastuti IAP, Ryalino C

    Open access Macedonian journal of medical sciences 2019; (7(6)):1025-1028 doi:10.3889/oamjms.2019.233.

    PMID: 30976354
  27. 27

    Clinical Profile and Visual Outcomes of Ocular Syphilis: A Five-year Review in Hospital Universiti Sains, Malaysia.

    Ghanimi Zamli AK, Irma Ngah NS, Chew-Ean T, et al.

    Cureus 2019; (11(2)):e4015 doi:10.7759/cureus.4015.

    PMID: 31007973
  28. 28

    Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis.

    Touhami S, Audo I, Terrada C, et al.

    Progress in retinal and eye research 2019; (72()):100761 doi:10.1016/j.preteyeres.2019.05.002.

    PMID: 31091471
  29. 29

    Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center.

    Posarelli C, Talarico R, Vella G, et al.

    Clinical rheumatology 2019; (38(10)):2917-2923 doi:10.1007/s10067-019-04585-3.

    PMID: 31172366
  30. 30

    Patterns of Uveitis among Patients Attending Jimma University Department of Ophthalmology, Jimma, Ethiopia.

    Tolesa K, Abateneh A, Kempen JH, Gelaw Y

    Ocular immunology and inflammation 2020; (28(7)):1109-1115 doi:10.1080/09273948.2019.1644348.

    PMID: 31429610
  31. 31

    The DNA Methylation Inhibitor Zebularine Controls CD4+ T Cell Mediated Intraocular Inflammation.

    Zou Y, Hu X, Schewitz-Bowers LP, et al.

    Frontiers in immunology 2019; (10()):1950 doi:10.3389/fimmu.2019.01950.

    PMID: 31475011
  32. 32

    Quality-of-Life and Psychosocial Aspects in Patients with Ocular Toxoplasmosis: A Clinical Study in a Tertiary Care Hospital in Brazil.

    Canamary AM, Monteiro IR, Machado Silva MKM, et al.

    Ocular immunology and inflammation 2020; (28(4)):679-687 doi:10.1080/09273948.2019.1612453.

    PMID: 31589483
  33. 33

    Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.

    Al-Janabi A, El Nokrashy A, Sharief L, et al.

    Ophthalmology 2020; (127(3)):410-416 doi:10.1016/j.ophtha.2019.08.031.

    PMID: 31607412
  34. 34

    Pattern of Intermediate Uveitis in an Egyptian Cohort.

    Abd El Latif E, Abdelhalim AS, Montasser AS, et al.

    Ocular immunology and inflammation 2020; (28(3)):524-531 doi:10.1080/09273948.2019.1668429.

    PMID: 31642742
  35. 35

    Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis.

    Testi I, Pavesio C

    Therapeutic delivery 2019; (10(10)):621-625 doi:10.4155/tde-2019-0051.

    PMID: 31663454
  36. 36

    Relationship of Epiretinal Membrane Formation and Macular Edema Development in a Large Cohort of Uveitic Eyes.

    Mustafi D, Do BK, Rodger DC, Rao NA

    Ocular immunology and inflammation 2021; (29(5)):915-921 doi:10.1080/09273948.2019.1704026.

    PMID: 31961201
  37. 37

    Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis.

    Zhong Z, Su G, Kijlstra A, Yang P

    Progress in retinal and eye research 2021; (80()):100866 doi:10.1016/j.preteyeres.2020.100866.

    PMID: 32422390
  38. 38

    [Uveitis Masquerade Syndrome: Typical Symptoms and Presentations].

    Biewald E, Rating P, Bechrakis NE, Lommatzsch AP

    Klinische Monatsblatter fur Augenheilkunde 2020; (237(5)):614-620 doi:10.1055/a-1120-8787.

    PMID: 32434245
  39. 39

    Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.

    Peñaranda-Henao M, Reyes-Guanes J, Muñoz-Ortiz J, et al.

    Ocular immunology and inflammation 2021; (29(7-8)):1366-1369 doi:10.1080/09273948.2020.1757120.

    PMID: 32469689
  40. 40

    UVEITIS TREATED WITH DEXAMETHASONE IMPLANT.

    Mathis T, Cerquaglia A, Weber M, et al.

    Retina (Philadelphia, Pa.) 2021; (41(3)):620-629 doi:10.1097/IAE.0000000000002901.

    PMID: 32618834
  41. 41

    Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets' Disease-Associated Uveitis: A Systematic Review and Meta-Analysis.

    Hu Y, Huang Z, Yang S, et al.

    Frontiers in pharmacology 2020; (11()):941 doi:10.3389/fphar.2020.00941.

    PMID: 32670062
  42. 42

    Immunological tests and their interpretation in uveitis.

    Rathinam SR, Tugal-Tutkun I, Agarwal M, et al.

    Indian journal of ophthalmology 2020; (68(9)):1737-1748 doi:10.4103/ijo.IJO_570_20.

    PMID: 32823389
  43. 43

    Multidisciplinary team care in advanced lung cancer.

    Kowalczyk A, Jassem J

    Translational lung cancer research 2020; (9(4)):1690-1698 doi:10.21037/tlcr.2019.11.33.

    PMID: 32953542
  44. 44

    Clinical Features of Japanese Patients with Ocular Inflammation and Their Surgical Procedures Over the Course of 20 Years.

    Takai N, Kobayashi T, Kida T, Ikeda T

    Clinical ophthalmology (Auckland, N.Z.) 2020; (14()):2799-2806 doi:10.2147/OPTH.S273938.

    PMID: 33061264
  45. 45

    Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.

    Suhler EB, Jaffe GJ, Fortin E, et al.

    Ophthalmology 2021; (128(6)):899-909 doi:10.1016/j.ophtha.2020.10.036.

    PMID: 33157077
  46. 46

    The Impact of Adult Uveitis on Quality of Life: An Exploratory Study.

    Prem Senthil M, Lim L, Braithwaite T, et al.

    Ophthalmic epidemiology 2021; (28(5)):444-452 doi:10.1080/09286586.2020.1856385.

    PMID: 33345711
  47. 47

    Topical Corticosteroids for Infectious Keratitis Before Culture-Proven Diagnosis.

    Hirano K, Tanaka H, Kato K, Araki-Sasaki K

    Clinical ophthalmology (Auckland, N.Z.) 2021; (15()):609-616 doi:10.2147/OPTH.S297202.

    PMID: 33623362
  48. 48

    Granulomatous Features in Juvenile Idiopathic Arthritis-Associated Uveitis is Not a Rare Occurrence.

    Papasavvas I, Herbort CP

    Clinical ophthalmology (Auckland, N.Z.) 2021; (15()):1055-1059 doi:10.2147/OPTH.S299436.

    PMID: 33727787
  49. 49

    Classification Criteria for Spondyloarthritis/HLA-B27-Associated Anterior Uveitis.

    American journal of ophthalmology 2021; (228()):117-125 doi:10.1016/j.ajo.2021.03.049.

    PMID: 33845004
  50. 50

    Structural Endpoints and Outcome Measures in Uveitis.

    Wintergerst MWM, Liu X, Terheyden JH, et al.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 2021; (244(5)):465-479 doi:10.1159/000517521.

    PMID: 34062542
  51. 51

    Prevalence and incidence rates and treatment patterns of non-infectious uveitis in Japan: real-world data using a claims database.

    Umazume A, Ohguro N, Okada AA, et al.

    Japanese journal of ophthalmology 2021; (65(5)):657-665 doi:10.1007/s10384-021-00850-8.

    PMID: 34181111
  52. 52

    Pediatric uveitis: A comprehensive review.

    Maleki A, Anesi SD, Look-Why S, et al.

    Survey of ophthalmology 2022; (67(2)):510-529 doi:10.1016/j.survophthal.2021.06.006.

    PMID: 34181974
  53. 53

    Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence?

    Renisi G, Lombardi A, Stanzione M, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2021; (110()):95-97 doi:10.1016/j.ijid.2021.07.035.

    PMID: 34289406
  54. 54

    [Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group].

    Heiligenhaus A, Rothaus K, Pleyer U

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2021; (118(9)):913-918 doi:10.1007/s00347-021-01486-2.

    PMID: 34459962
  55. 55

    Adalimumab in patients with vision-threatening uveitis: real-world clinical experience.

    Tang Lee Say TL, Yang V, Fingret JM, et al.

    BMJ open ophthalmology 2021; (6(1)):e000819 doi:10.1136/bmjophth-2021-000819.

    PMID: 34632076
  56. 56

    Correlation of Clinical Aqueous Flare Grading to Semi-Automated Flare Measurements Using Laser Flare Photometry.

    Halim MS, Hasanreisoglu M, Onghanseng N, et al.

    Ocular immunology and inflammation 2022; (30(7-8)):1906-1912 doi:10.1080/09273948.2021.1971723.

    PMID: 35081012
  57. 57

    Reply on Comments on the paper "Clinical characteristics and treatment of pars planitis: an adalimumab experience" by Ozdemir et al.

    Ozdemir HB, Ozdal PC

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2022; (260(6)):2067 doi:10.1007/s00417-021-05528-y.

    PMID: 35088114
  58. 58

    Optical Coherence Tomography Findings in Infectious Posterior Uveitis.

    Pichi F, Curi ALL, Vasconcelos-Santos DV, et al.

    Ocular immunology and inflammation 2022; (30(3)):652-663 doi:10.1080/09273948.2022.2032197.

    PMID: 35226572
  59. 59

    Real-World outcomes of adalimumab in adults with non-infectious uveitis.

    Leal I, Wong SW, Giuffre C, et al.

    Acta ophthalmologica 2022; (100(7)):e1496-e1502 doi:10.1111/aos.15120.

    PMID: 35277918
  60. 60

    Long-Term Follow-up of Patients With Uveitis Treated With Adalimumab: Response Rates and Reasons for Discontinuation of Therapy.

    Eurelings LEM, Missotten TOAR, van Velthoven MEJ, et al.

    American journal of ophthalmology 2022; (240()):194-204 doi:10.1016/j.ajo.2022.03.017.

    PMID: 35314190
  61. 61

    Targeted Medical History and Diagnostic Testing in Uveitis.

    Grajewski RS, Tappeiner C, Thurau S

    Klinische Monatsblatter fur Augenheilkunde 2022; (239(5)):654-658 doi:10.1055/a-1737-4306.

    PMID: 35320872
  62. 62

    Risk of Elevated Intraocular Pressure With Difluprednate in Patients With Non-Infectious Uveitis.

    Yakin M, Kumar A, Kodati S, et al.

    American journal of ophthalmology 2022; (240()):232-238 doi:10.1016/j.ajo.2022.03.026.

    PMID: 35381204
  63. 63

    Intermediate Uveitis: A Review.

    Teo AYT, Betzler BK, Hua KLQ, et al.

    Ocular immunology and inflammation 2023; (31(5)):1041-1060 doi:10.1080/09273948.2022.2070503.

    PMID: 35759636
  64. 64

    Th17 Activation and Th17/Treg Imbalance in Prolonged Anterior Intraocular Inflammation after Ocular Alkali Burn.

    Yuan M, Qian X, Huang Y, et al.

    International journal of molecular sciences 2022; (23(13)) doi:10.3390/ijms23137075.

    PMID: 35806082
  65. 65

    The Role of Corticosteroids in Treating Acute Ocular Toxoplasmosis in an Immunocompetent Patient: A Case Report.

    Lin HY, Lee WA

    Frontiers in medicine 2022; (9()):843050 doi:10.3389/fmed.2022.843050.

    PMID: 35847774
  66. 66

    Bilateral Panuveitis and Exudative Retinal Detachments Associated with Alpelisib.

    Chong YJ, Azzopardi M, Tallouzi MO, et al.

    Case reports in oncology 2022; (15(2)):713-719 doi:10.1159/000525772.

    PMID: 36157688
  67. 67

    Long-Acting Fluocinolone Acetonide Intravitreal Implant for Recurrent Bilateral Non-Infectious Posterior Uveitis.

    Babel AT, Chin EK, Almeida DRP

    International medical case reports journal 2022; (15()):665-669 doi:10.2147/IMCRJ.S384356.

    PMID: 36444172
  68. 68

    SUSTAINED-RELEASE LOW-DOSE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA: TWO CASE REPORTS.

    Kiernan DF

    Retinal cases & brief reports 2024; (18(4)):421-427 doi:10.1097/ICB.0000000000001404.

    PMID: 36657153
  69. 69

    Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile.

    Achten R, van Luijk C, Thijs J, et al.

    Ocular immunology and inflammation 2024; (32(7)):1150-1154 doi:10.1080/09273948.2023.2182325.

    PMID: 36854134
  70. 70

    Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?

    Korman BD, Lachant DJ, Castelino FV

    Rheumatic diseases clinics of North America 2023; (49(2)):345-357 doi:10.1016/j.rdc.2023.01.015.

    PMID: 37028839
  71. 71

    Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry.

    Vitale A, Casa FD, Guerriero S, et al.

    Ophthalmology and therapy 2023; (12(4)):1957-1971 doi:10.1007/s40123-023-00712-1.

    PMID: 37166627
  72. 72

    Behçet's Disease Uveitis.

    Joubert M, Desbois AC, Domont F, et al.

    Journal of clinical medicine 2023; (12(11)) doi:10.3390/jcm12113648.

    PMID: 37297843
  73. 73

    Berlin nodules: About 3 cases.

    Kharrat M, Kallel Z, Sayadi S, et al.

    European journal of ophthalmology 2024; (34(1)):NP133-NP137 doi:10.1177/11206721231187665.

    PMID: 37438949
  74. 74

    Anxiety and depression in patients with uveitis: a comprehensive review of observational studies.

    Choo CH, Gonzales J, Shantha JG

    Current opinion in ophthalmology 2023; (34(6)):543-549 doi:10.1097/ICU.0000000000000999.

    PMID: 37729665
  75. 75

    Pediatric Pars Planitis: A Review.

    Khochtali S, Ozdal P, AlBloushi AF, et al.

    Ocular immunology and inflammation 2023; (31(10)):1915-1929 doi:10.1080/09273948.2023.2279683.

    PMID: 37976519
  76. 76

    The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India.

    Biswas J, Tyagi M, Agarwal M,

    Ophthalmology science 2024; (4(1)):100403 doi:10.1016/j.xops.2023.100403.

    PMID: 38027419
  77. 77

    Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy.

    Tomkins-Netzer O, Niederer R, Greenwood J, et al.

    Progress in retinal and eye research 2024; (99()):101245 doi:10.1016/j.preteyeres.2024.101245.

    PMID: 38242492
  78. 78

    Clinical profile and treatment outcomes in pediatric uveitis - A series from South India.

    Mooss VS, Babu K

    Indian journal of ophthalmology 2024; (72(Suppl 4)):S584-S591 doi:10.4103/IJO.IJO_3131_22.

    PMID: 38317316
  79. 79

    Masquerade syndrome: A review of uveitic imposters.

    Dutta Majumder P, Khetan V, Biswas J

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2024; (13(2)):100054 doi:10.1016/j.apjo.2024.100054.

    PMID: 38583526
  80. 80

    Prevalence, clinical characteristics, and independent predictors of uveitic macular edema in an Asian population: a retrospective cohort study.

    Tungsattayathitthan U, Jenjanya S, Choopong P, et al.

    BMC ophthalmology 2024; (24(1)):181 doi:10.1186/s12886-024-03447-0.

    PMID: 38649909
  81. 81

    Work Productivity and Activities of Daily Living in Working Patients with Uveitis.

    Sánchez Sevila JL, Rosas Gómez de Salazar J, Seguí Crespo M

    Ocular immunology and inflammation 2024; (32(10)):2306-2313 doi:10.1080/09273948.2024.2343071.

    PMID: 38652637
  82. 82

    Management of Acute Non-Infectious Anterior Uveitis in Adults - Practice Patterns Among Uveitis Specialists in North America.

    Zhang H, Nicholson CM, Kempen JH, et al.

    Ocular immunology and inflammation 2025; (33(7)):1153-1158 doi:10.1080/09273948.2024.2346819.

    PMID: 38749068
  83. 83

    American Society of Retina Specialists Clinical Practice Guidelines on Multimodal Imaging for Retinal Disease.

    Ramakrishnan MS, Kovach JL, Wykoff CC, et al.

    Journal of vitreoretinal diseases 2024; (8(3)):234-246 doi:10.1177/24741264241237012.

    PMID: 38770073
  84. 84

    Syphilitic Uveitis With Diverse Clinical Presentations: Multimodal Imaging as a Useful Adjunctive Tool for Diagnosis and Treatment.

    Kawamoto S, Hiyama T, Sada I, Harada Y

    Cureus 2024; (16(5)):e59791 doi:10.7759/cureus.59791.

    PMID: 38846191
  85. 85

    The Spectrum of Presumed Tubercular Uveitis in a Referral Eye Clinic in Qatar.

    Helal RS, Attia S, Al-Baker ZM, et al.

    Ocular immunology and inflammation 2025; (33(1)):105-112 doi:10.1080/09273948.2024.2368668.

    PMID: 38981050
  86. 86

    Development of a Consensus Guideline for the Diagnosis and Management of Chronic Noninfectious Uveitis Affecting the Posterior Segment.

    Singh RP, Albini TA, Baumal CR, et al.

    Ophthalmic surgery, lasers & imaging retina 2024; (55(11)):652-658 doi:10.3928/23258160-20240625-01.

    PMID: 39254498
  87. 87

    Tocilizumab for cystoid macular edema secondary to retinitis pigmentosa.

    Abramowicz S, Kamgang Semeu P, Nubourgh I, et al.

    Journal of ophthalmic inflammation and infection 2024; (14(1)):47 doi:10.1186/s12348-024-00430-0.

    PMID: 39349884
  88. 88

    Epidemiology of Intermediate Uveitis.

    Besagar S, de-la-Torre A, Thorne J, et al.

    Ocular immunology and inflammation 2025; (33(4)):503-511 doi:10.1080/09273948.2024.2408411.

    PMID: 39360991
  89. 89

    Ocular Syphilis: The Resurgence of an Old Disease Experience of a Tertiary Centre in Portugal.

    Costa C, Machado T, Zhu A, et al.

    Ocular immunology and inflammation 2025; (33(3)):385-395 doi:10.1080/09273948.2024.2413902.

    PMID: 39388630
  90. 90

    Early Immunosuppressive Therapy and Ocular Complications in Pediatric and Young Adult Patients with Non-Infectious Uveitis at a Tertiary Referral Center in Japan.

    Sada I, Hiyama T, Orihashi Y, et al.

    Ocular immunology and inflammation 2024; (32(10)):2459-2466 doi:10.1080/09273948.2024.2409394.

    PMID: 39436950
  91. 91

    Humanistic Burden of Noninfectious Uveitis: A Systematic Review and Meta-Analysis.

    Sriranganathan A, Grad J, Miranda RN, et al.

    American journal of ophthalmology 2025; (271()):43-59 doi:10.1016/j.ajo.2024.10.027.

    PMID: 39522581
  92. 92

    Sympathetic Ophthalmia Following an Evisceration Surgery-A Case Report.

    Javed R, Al-Khairy S, Khan H, et al.

    Clinical case reports 2024; (12(12)):e9626 doi:10.1002/ccr3.9626.

    PMID: 39610991
  93. 93

    Atypical presentation of acute retinal necrosis mimicking Vogt-Koyanagi-Harada disease leading to misdiagnosis: a case report.

    Zhu W, Yu C, Guo Q, et al.

    Frontiers in medicine 2024; (11()):1468801 doi:10.3389/fmed.2024.1468801.

    PMID: 39650189
  94. 94

    Correlation of Anterior Segment Optical Coherence Tomography and Slit-Lamp Imaging in Infectious Keratitis.

    Elzawahry F, Rossi C, Said D, Dua HS

    Cornea 2025; (44(11)):1388-1394 doi:10.1097/ICO.0000000000003788.

    PMID: 39791940
  95. 95

    Demographic Features, Diagnoses and Real-World Clinical Management of Uveitis in Japan.

    Hayashi I, Keino H, Nakayama M, et al.

    Ocular immunology and inflammation 2025; (33(7)):1077-1085 doi:10.1080/09273948.2024.2449179.

    PMID: 39792467
  96. 96

    Preoperative Optimization Strategies in Elective Spine Surgery.

    Daniels AH, Singh M, Knebel A, et al.

    JBJS reviews 2025; (13(2)) doi:10.2106/JBJS.RVW.24.00210.

    PMID: 39903820
  97. 97

    The epidemiology of uveitis: comparison of its causes and visual outcomes between three-tiered medical facilities in Ube city.

    Yanai R, Uchi SH, Kondo Y, et al.

    Scientific reports 2025; (15(1)):8998 doi:10.1038/s41598-025-93223-x.

    PMID: 40089526
  98. 98

    Epidemiology of Uveitis from a Tertiary Referral Hospital in Bulgaria over a 13-Year Period.

    Mitkova-Hristova VT, Atanassov MA, Basheva-Kraeva YM, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(7)) doi:10.3390/diagnostics15070828.

    PMID: 40218176
  99. 99

    Safety of Mycophenolate Mofetil in the Treatment of Non-Infectious Uveitis and Sclerouveitis in Japanese Patients: A Feasibility Study.

    Hiyama T, Komatsu K, Harada Y

    Ocular immunology and inflammation 2025; (33(7)):1303-1312 doi:10.1080/09273948.2025.2492773.

    PMID: 40262603
  100. 100

    Evidence and Consensus-Based Imaging Guidelines in Multifocal Choroiditis With Panuveitis and Punctate Inner Choroiditis-Multimodal Imaging in Uveitis (MUV) Taskforce Report 5.

    Gangaputra S, Agarwal A, Norel JO, et al.

    American journal of ophthalmology 2025; (276()):272-285 doi:10.1016/j.ajo.2025.04.018.

    PMID: 40288596
  101. 101

    Egyptian Consensus Guidance for Treatment of Adults with Non-Infectious Uveitis.

    El-Ghobashy N, El-Garf A, Mohamed Youssef M, et al.

    Ocular immunology and inflammation 2025; (33(7)):1313-1318 doi:10.1080/09273948.2025.2493362.

    PMID: 40314690
  102. 102

    Non-infectious uveitis: a multicenter study from Argentina.

    Virasoro BM, Kostianovsky A, Milesi F, et al.

    International ophthalmology 2025; (45(1)):186 doi:10.1007/s10792-025-03555-w.

    PMID: 40343596
  103. 103

    Prevalence, Treatment Patterns, and Outcomes of Pediatric Noninfectious Uveitis in the United States: An IRIS Registry Analysis.

    Uner OE, Lin P, Kopplin LJ, et al.

    Ophthalmology. Retina 2025; (9(11)):1106-1113 doi:10.1016/j.oret.2025.05.006.

    PMID: 40349981
  104. 104

    Where Do We Stand in the Management of Rheumatoid Arthritis Ahead of EULAR/ACR 2025?

    Vlad AL, Popazu C, Lescai AM, et al.

    Clinics and practice 2025; (15(6)) doi:10.3390/clinpract15060103.

    PMID: 40558221
  105. 105

    Etiology and Anatomical Location of Uveitis-Prognostic Factors for Disease Course and Laterality.

    Mitkova-Hristova VT, Atanassov MA

    Life (Basel, Switzerland) 2025; (15(6)) doi:10.3390/life15060882.

    PMID: 40566536
  106. 106

    Vision-Related Quality of Life and Work Performance in Actively Working Patients with Uveitis: A Quantitative Cross-Sectional Study.

    Sánchez Sevila JL, Rosas J, Ramada Rodilla JM, Seguí-Crespo M

    Ocular immunology and inflammation 2025; (33(9)):1987-1994 doi:10.1080/09273948.2025.2544731.

    PMID: 40824898
  107. 107

    Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry.

    Gaggiano C, De-la-Torre A, Cardona-López J, et al.

    Ophthalmology and therapy 2025; (14(11)):2877-2894 doi:10.1007/s40123-025-01237-5.

    PMID: 40983853
  108. 108

    Evolving landscape of small-molecule immunotherapeutics for uveitis: a scoping review.

    Yim TSY, Cifuentes-González C, Agrawal R, Oon HH

    Drug discovery today 2025; (30(12)):104515 doi:10.1016/j.drudis.2025.104515.

    PMID: 41161567
  109. 109

    Paediatric Neoplastic Uveitis Masquerade Syndromes.

    Asghar E, Puthussery JC, de Boer J, Miraldi Utz V

    Ocular immunology and inflammation 2026; (34(2)):229-241 doi:10.1080/09273948.2025.2594660.

    PMID: 41401403
  110. 110

    Ten-Year Registry Analysis of Ocular Inflammation in Taiwan: Distinct Clinical Patterns and Systemic Associations in Adults and Children.

    Sun WH, Wang LU, Wang JK, et al.

    Ocular immunology and inflammation 2026; (34(2)):325-333 doi:10.1080/09273948.2025.2607621.

    PMID: 41529241
  111. 111

    Clinical Features and Risk Factors for Chronic Syphilitic Uveitis.

    Sureshkumar H, Song A, Nguyen NV, et al.

    Ocular immunology and inflammation 2026; (34(3)):498-504 doi:10.1080/09273948.2026.2626810.

    PMID: 41678724
  112. 112

    A typical Vitelliform-Like Maculopathy Secondary to Bartonella henselae Neuroretinitis.

    Illiano W, Crosson J

    Journal of vitreoretinal diseases 2026; 24741264261418514 doi:10.1177/24741264261418514.

    PMID: 41727755
  113. 113

    Metabolic checkpoints in the regulation of Th17 cells: implications for uveitis pathogenesis and therapy.

    Ma Y, Zhang Q, Ding Z

    Frontiers in immunology 2026; (17()):1690141 doi:10.3389/fimmu.2026.1690141.

    PMID: 41743733